Evidence map›Paper›PMID 32164327›Full record

ArticleInternational journal of molecular sciences2020

Functional Consequences of Low Activity of Transport System A for Neutral Amino Acids in Human Bone Marrow Mesenchymal Stem Cells.

Martina Chiu, Giuseppe Taurino, Massimiliano G Bianchi, Erica Dander, Alessandra Fallati, Nicola Giuliani, Giovanna D'Amico, Ovidio Bussolati

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Martina ChiuDepartment of Medicine and Surgery, University of Parma, 43125 Parma, Italy.ORCID 0000-0002-5655-9984
Giuseppe TaurinoDepartment of Medicine and Surgery, University of Parma, 43125 Parma, Italy.ORCID 0000-0001-9606-1171
Massimiliano G BianchiDepartment of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Erica DanderCentro Ricerca Tettamanti, Pediatric Dept., University of Milano-Bicocca, Fondazione MBBM, 20900 Monza, Italy.
Alessandra FallatiCentro Ricerca Tettamanti, Pediatric Dept., University of Milano-Bicocca, Fondazione MBBM, 20900 Monza, Italy.
Nicola GiulianiDepartment of Medicine and Surgery, University of Parma, 43125 Parma, Italy.ORCID 0000-0003-3457-3774
Giovanna D'AmicoCentro Ricerca Tettamanti, Pediatric Dept., University of Milano-Bicocca, Fondazione MBBM, 20900 Monza, Italy.
Ovidio BussolatiDepartment of Medicine and Surgery, University of Parma, 43125 Parma, Italy.ORCID 0000-0002-4301-2939

Funding

Associazione Italiana per la Ricerca sul Cancro 19272Associazione Italiana per la Ricerca sul Cancro 20299Associazione Italiana per la Ricerca sul Cancro 23354
6 · The paper itself

Abstract

In cultured human fibroblasts, SNAT transporters (System A) account for the accumulation of non-essential neutral amino acids, are adaptively up-regulated upon amino acid deprivation and play a major role in cell volume recovery upon hypertonic stress. No information is instead available on the expression and activity of SNAT transporters in human bone marrow mesenchymal stromal cells (MSC), although they are increasingly investigated for their staminal and immunomodulatory properties and used for several therapeutic applications. The uptake of glutamine and proline, two substrates of SNAT1 and SNAT2 transporters, was measured in primary human MSC and an MSC line. The amino acid analogue MeAIB, a specific substrate of these carriers, has been used to selectively inhibit SNAT-dependent transport of glutamine and, through its sodium-dependent transport, as an indicator of SNAT1/2 activity. SNAT1/2 expression and localization were assessed with RT-PCR and confocal microscopy, respectively. Cell volume was assessed from urea distribution space. In all these experiments, primary human fibroblasts were used as the positive control for SNAT expression and activity. Compared with fibroblasts, MSC have a lower SNAT1 expression and hardly detectable membrane localization of both SNAT1 and SNAT2. Moreover, they exhibit no sodium-dependent MeAIB uptake or MeAIB-inhibitable glutamine transport, and exhibit a lower ability to accumulate glutamine and proline than fibroblasts. MSC exhibited an only marginal increase in MeAIB transport upon amino acid starvation and did not recover cell volume after hypertonic stress. In conclusion, the activity of SNAT transporters is low in human MSC. MSC adaptation to amino acid shortage is expected to rely on intracellular synthesis, given the absence of an effective up-regulation of the SNAT transporters.

Indexed as

Amino Acids, NeutralAmino Acid Transport System Abeta-AlanineCell Culture TechniquesCell MembraneCells, CulturedCulture MediaFibroblastsGlutamineHumansMesenchymal Stem CellsProlineProtein Transport2,2-dimethyl-beta-alanineAmino Acids, NeutralAmino Acid Transport System Abeta-AlanineCulture MediaGlutamineProlineSLC38A1 protein, humanSLC38A2 protein, humanadaptive regulationamino acid starvationcell volumeglutaminehypertonic stressMeAIBmesenchymal stem cellsprolineSNAT1System A

Identifiers

PMID32164327
PMCPMC7084684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.